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Abstract
Ketamine administration has been associated with controversial behavioural impairments and psychotic epi-
sodes. Even though ketamine alone and in combination with midazolam or dexmedetomidine are frequently
used in laboratory animals, the side-effects of such protocols are not well known. Therefore, our aim was to
evaluate the effects of ketamine alone and in combination with midazolam or dexmedetomidine on emotional
reactivity, as well as the effects on learning and memory in adult rats at least 48 h after anaesthesia.
The evaluation of the potential influence of 100 mg/kg ketamine administered alone and in combination with
midazolam (5 mg/kg), or dexmedetomidine (0.25 mg/kg) on spatial learning and recognition memory was stu-
died in adult Wistar rats using the radial maze as well as object recognition and location tests. The influence of
these combinations on emotional reactivity was investigated using the new exploration test and the elevated
plus maze. Results showed that ketamine alone or in combination with midazolam or dexmedetomidine
affected neither spatial and recognition memory, nor emotional reactivity. These results reinforce the safe
clinical use of ketamine and its combinations in rats in a research context since the administration of these
anaesthetic combinations did not produce significant changes with regard to spatial and recognition memory or
emotional reactivity. Furthermore, these results indicate that the quality of scientific data produced in adult rat
neurobehavioural research is not jeopardized by the use of these anaesthetic protocols.
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Anaesthesia is used during surgery and other interven-
tions to control pain, anxiety and consciousness. In
veterinary practice, anaesthesia is also essential in
immobilizing animals for clinical examination.1,2
Likewise, anaesthesia is required for several procedures
in research involving laboratory animals, especially in
neurobiological research.
All experiments using laboratory animals should be
based on the ‘three R principle’: refinement, replacement
and reduction.3 Refinement of anaesthesia should act as
an important parameter in consideration of, not only the
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promotion of animal welfare, but also the avoidance of
anaesthetics that may interfere with experimental results.
In research using laboratory animals theN-methyl-D-
aspartate (NMDA) antagonist ketamine is probably the
most frequently used anaesthetic. In humans, ketamine is
described as a dissociative anaesthetic and is still used
worldwide in clinical settings4 and in emergencies.5
The use of ketamine is limited because of its psychotic
side-effects,6 which can be overcome by finding a
balanced anaesthesia. This technique allows for safe
anaesthesia by decreasing the doses required for each
individual drug and still achieving a clinical effect.
Therefore, ketamine is frequently used in combination
with midazolam or dexmedetomidine.7,8 Besides provid-
ing anterograde amnesia, the benzodiazepine midazolam
is also used as a sedative and anxiolytic compound.9
Dexmedetomidine is a recent a2-adrenergic agonist
that also induces sedation, anxiolysis, and analgesia.10
Acute and repeated sub-anaesthetic doses of ketamine
have been reported to impair cognition in humans11 and
rodents.12,13However, acute ketamine administration has
also been shown to attenuate post-operative cognitive
dysfunction.14Regardlessofall the evidence, the literature
is nonetheless scarce regarding the effects of ketamine in
combination with dexmedetomidine or with midazolam
on long-term memory. Studies in humans have reported
that these combinations produce anterograde amnesia
and anxiolysis, and reduce the side-effects related with
ketamine.15,16 The ketamine/midazolam combination
also causes transient anddose-dependentmemory impair-
ment.15,17Our grouphas recently reported that this anaes-
thetic combination did not disrupt the learning process of
mice during a spatial task,18,19 and that ketamine com-
bined with medetomidine also did not affect their per-
formance in the T-maze test.20 Thus, it has become
imperative to evaluate the cognitive functions of rats
after being subjected to these anaesthetic protocols.
Therefore, in the present study,we evaluated the effects
of the ketamine alone and in combination with midazo-
lam or dexmedetomidine on emotional reactivity, and on
learning and memory in rats – one of the most frequently
used animal models in neuroscience research. This study
attempts to replicate what happens in research and con-
tributes to the refinement of anaesthesia in laboratory
animals by evaluating this combination when rats are
anaesthetized and used in neurobehavioural research.
Materials and methods
Animals
Eighty-two male Wistar rats (from the colony of the
Institute of Molecular and Cell Biology, University of
Porto, Portugal) aged 10–12 weeks were used in the
study. Rats were housed in pairs in a controlled
environment (20 2C, 45–55% humidity) with a 12h
light/dark cycle.Foodandwaterwere suppliedad libitum.
All behavioural experiments were performed during the
dark phase, except for the elevated plus maze (EPM) test.
All procedures were carried out under personal and pro-
ject licences approvedby thenational authority for animal
protection, ‘Direc¸a˜o Geral de Alimentac¸a˜o e Veterina´ria’
(Lisbon, Portugal), and were performed in accordance
with the European Directive 2010/63/EU on the protec-
tion of animals used for scientific purposes.
Anaesthesia
Ketamine (Imalgene 1000, Merial, Lisbon, Portugal;
100mg/mL), midazolam (B Braun Medical, Barcelona,
Spain; 5mg/mL), and dexmedetomidine (Dexdomitor,
Esteve Farma, Lda, Carnaxide, Portugal, 0.5mg/mL)
were dissolved in a sterile saline solution (Braun Vet,
Queluz de Baixo, Portugal) before intraperitoneal injec-
tion at 1mL/kg of body weight. Rats were randomly dis-
tributed into four groups: CONTROL (saline solution,
n¼ 18), 100mg/kg ketamine (KET, n¼ 19), 100mg/kg
ketamine and 5mg/kg midazolam (KET/MID, n¼ 19),
and 100mg/kg ketamine and 0.25mg/kg dexmedetomi-
dine (KET/DEX, n¼ 19); the combination of drugs was
administered in a single injection. In addition to the
groups previously referred to, and in order to evaluate
emotional reactivity using the EPMtest and to avoid pro-
longed periods of anaesthesia, KET/DEX (100mg/kg
and 0.25mg/kg) anaesthesia was reverted using atipame-
zole (Antisedan, Pfizer, Oeiras, Portugal; 5mg/mL) one
hour after loss of righting reflex (KET/DEXþA).
After anaesthetic administration, the animals were
isolated until righting reflex was lost. Subsequently, ani-
mals were placed on a homeothermic blanket, connected
to a rectal thermal probe (50-7061-F; Harvard
Apparatus Ltd, Kent, UK) to maintain a body tempera-
ture at 37 1C. During anaesthesia, rats received
oxygen through a facemask, and their eyes were kept
humid with sterile saline solution. Oxygen saturation
wasmaintained between 90 and 99%using a pulse oxim-
etry (Vitalstore Multimonitor base unit; Vetronics,
Devon, UK) with a sensor placed in the hindlimb of
each animal. Respiratory and pulse rates were measured
using the same equipment every 5min. Time to lose and
time to gain the righting reflex were also recorded.
Experiment 1: Evaluation of the potential
influence of ketamine alone and combined
with midazolam or dexmedetomidine on
spatial learning and recognition memory
The cognitive status was assessed in the eight-radial
maze and in the object recognition and location
(OR/L) tests. Forty-eight animals were randomly dis-
tributed between the radial maze and the OR/L tests.
Six animals were allocated to each of the experimental
groups (CONTROL, KET, KET/MID and KET/
DEX). The radial maze training and the habituation
to OR/L started 48 h after the anaesthesia protocols.
Radial maze test. Working and reference memories
were assessed simultaneously through a fixed position
of reward task, in which three of the arms were baited
and their positions were fixed throughout the training
trials. The entry into the never-baited arm was con-
sidered to be a reference memory (RM) error. Within
a training session, the re-entry into one of the arms was
considered a working memory (WM) error.21 The
response latency was defined as the total duration of
the experiment and the total number of visited arms.
The radial maze was made of black Plexiglas
(Panlab, SLU, Barcelona, Spain) and elevated 50 cm
from the ground. It consisted of a central area with
eight sliding doors giving access to eight equally-sized
arms. For reinforcement, three sugar pellets (Bio-Serv,
Frenchtown, NJ, USA) were placed in the distal end of
each arm. External-maze cues were added to aid navi-
gation. The amount of time a rat took to complete a
trial was recorded. During experiments, animals had
restricted access to food, and were being fed only fol-
lowing testing. The body weight loss of animals was
kept below 10%.
Habituation began five days before the training
period. On three consecutive days, sugar pellets were
distributed and rats were allowed to individually
explore the maze for 5min or until the pellets were
consumed. Twenty-four hours after the habituation
period, animals were anaesthetized.
Training started 48 h after anaesthesia, with daily
sessions (five trials per session) over a nine-day
period. At the beginning of each trial, rats were
placed in the centre of the maze and always facing the
same arm, and were allowed to explore the maze for
5min or until all the pellets were consumed. An arm
entry was confirmed when all four paws were inside the
arm of the maze. After each session animals were
returned to their home cage and were fed. Between ses-
sions, the maze was cleansed with absorbing paper and
a 30% ethanol solution to minimize the olfactory cues.
In addition to minimizing these cues, maze rotation was
made between trials.
Object recognition/location test. The OR test was per-
formed as described in a previous work.13 Briefly, the
test apparatus consisted of an open box and the objects
used were made of plastic, glass or metal in three dif-
ferent shapes: cubes, pyramids and cylinders. The test
consisted of three phases.
Habituation began 48 h after anaesthesia and rats
were allowed to explore the apparatus for 10min, over
five consecutive days. In all sessions, the arena con-
tained a single object (a familiar object) placed in the
centre. The following day, sample phase OR1 started
by placing each rat in the apparatus with two identical
objects (familiar) for 3min and then the rat was
removed to its home cage. The choice phases were
performed after a 15min (OR2) and 24 h (OR3)
delay. In this phase the apparatus contained a novel
object and a copy of the previously seen famil-
iar object, and animals were allowed to explore the
objects for 3min. The time spent exploring the novel
object served as the measure of recognition memory
for the familiar object. Exploration was defined as
follows: rat touched the object with its nose or the
rat’s nose was directed toward the object at a distance
shorter than 2 cm. Circling or sitting on the object was
not considered to be exploratory behaviours. The
index of discrimination was calculated as the differ-
ence between exploration time of the novel and famil-
iar objects.22
OL testing was performed 24 h after the OR test. The
sample phase of the OL1 test was exactly the same as
for the recognition test. After a retention interval of
15min, the rat was returned to the apparatus for
3min with both objects, one of which was placed in
the previously used location, and the other placed
near the adjacent corner, a new location – choice
phase (OL2). This task assessed the ability to discrim-
inate the novelty of the OL.22 Data from the OR/L tests
were analysed using the Observer 10 software (Noldus
Information Technology, Wageningen, The
Netherlands).
Experiment 2: Evaluation of the potential
influence of ketamine alone and combined
with midazolam or dexmedetomidine on
emotional reactivity
The emotional behaviours were assessed in the new
object exploration (NOE) test and the EPM test 48 h
after anaesthesia. Thirty-four animals were randomly
distributed to each of the experimental groups (KET,
KET/MID, KET/DEX and KET/DEXþA, n¼ 7,
except CONTROL with n¼ 6) in the EPM test. The
24 animals used in the NOE were the same as those
used during the first day of habituation to OR/L.
Tests began 48 h after anaesthesia.
All behaviours were video-recorded with a camera
placed above the apparatus and saved to a computer by
the multi-camera vigilance GeoVision system (GV-800/
8; GeoVision Inc, Taipei, Taiwan). Behaviours were
analysed using the Observer 10 software.
New object exploration test. In this test, each rat was
placed in the open box facing away from the test object,
which was placed in the centre of the open box, and
allowed to explore the environment for 10min. The
pattern of space occupation, frequency and duration
of behaviours towards the object were recorded.
Elevated plus maze test. The EPM was made of dark
grey plastic and positioned 50 cm above the floor. The
maze consisted of four arms arranged in the shape of a
cross, two arms had surrounding walls (closed arms)
and the other two opposing arms had no walls (open
arms). A test session was started by placing each rat on
the central platform, facing an open arm. Over a period
of 5min, each rat’s exploration was video-recorded.
The maze was cleansed after each training session.
The number of open and closed arm entries, and the
time spent in the different compartments of the maze
(central platform, open and closed arms) were scored.
As mentioned previously, the KET/DEXþA group was
added to this test in order to clarify the potential influ-
ence of anaesthesia duration on anxiety.
Statistical analysis
The number of animals used per group was based on
previous work23,24 with a power of 0.8 and a¼ 0.05.
Parametric data were analysed with one-way analysis
of variance (ANOVA) and the paired Student’s t-test
(OR/L data for comparisons between groups and for
differences within groups, respectively), and ANOVA
for repeated measures with Bonferroni post hoc tests
(random access memory (RAM) data with anaesthesia
groups as a between-subject factor and day of testing as
a within-subject factor). These were expressed as
meanþSEM. Non-parametric data, such as anaes-
thetic parameters and NOE data, were analysed with
the Kruskal–Wallis test followed by the Mann–
Whitney U-test and expressed as median and 95% con-
fidence intervals. A value of P 0.05 was considered to
be statistically significant.
All results were analysed using Prism 6 for data
management and SPSS 16.0 (Apache Software
Foundation, Forest Hill, MD, USA) for statistical
analysis.
Results
Anaesthesia
Both the loss of consciousness and the anaesthesia
induction time were similar between groups. The
KET/MID group had a significantly higher heart rate
compared with the KET/DEX and KET/DEXþA
groups at several time points (5, 10, 25, 30 and
45min; P 0.043), and the KET group had a higher
heart rate than the KET/DEXþA group at 10min
(P¼ 0.039); no differences were detected between
groups regarding the respiratory rate (Table 1).
Anaesthesia induction times were significantly different
between groups (H (2)¼ 44.53; P 0.014). The KET
group took less time to recover their righting reflex
(31.2 [24.6–37.9] min), followed by the KET/MID
(60.1 [50.0–70.3] min) and the KET/DEX (228.3
[198.1–258.4] min) groups. KET/DEXþA anaesthesia
duration was not evaluated since the anaesthesia was
reverted after one hour.
Behavioural tests
Experiment 1. Animals ranging from 205 to 315 g were
used in all behavioural tests; no body weight loss higher
than 10% was observed.
The analysis of the radial arm maze data revealed a
main effect of day for response latency [F(1,22)¼ 30.995,
P< 0.001], for working memory [F(1,22)¼ 12.01,
P< 0.001] and reference memory [F(1,22)¼ 27.551,
P< 0.001] errors. However, there was no main effect of
treatment (P> 0.05) or treatment/day interactions
(P> 0.05). In all groups the number of reference and
working memory errors decreased across learning ses-
sions (Figure 1a and b).
After the habituation phase (Figure 2a), data from
OR/L showed no differences between groups. All sub-
jects recognized the novelty of the object, as indicated
by the significant increase in exploration of the new
object (i.e. robust recognition memory) during the
short delay of 15min (OR2; CONTROL t¼6.529,
P< 0.001; KET t¼7.260, P< 0.001; KET/MID
t¼6.422, P< 0.001; KET/DEX t¼5.053,
P< 0.01), and during the long-term delay of 24 h
(OR3; CONTROL t¼10.736, P< 0.001; KET
t¼5.33, P< 0.01; KET/MID t¼6.024, P< 0.01;
KET/DEX t¼3.532, P< 0.05). Furthermore, no dif-
ferences between groups were found in the discrimin-
ation index (proportion of exploration time) in OR2
and OR3 (Figure 2b and c). Rats from all experimental
groups also recognized the object displacement (new
location), as indicated by the preferential exploration
compared with the object in the familiar location (OL2;
CONTROL t¼10.253, P< 0.001; KET t¼9.067,
P< 0.001; KET/MID t¼7.832, P< 0.001; KET/
DEX t¼8.543, P< 0.001). No differences between
groups were found in the discrimination index in
OL2 (Figure 2d).
Experiment 2. In the NOE test, the Kruskal–Wallis
and Mann–Whitney results revealed that KET/DEX
rats spent more time in the corners (173.0 [49.7–297.3]
s) when compared with the CONTROL rats
Table 1. Physiological parameters during 60 min of anaesthesia.
Time
(min)
Physiological
parameters KET KET/MID KET/DEX KET/DEXþA
5 Heart rate (bpm) 360.7 (307.2–414.3) 403.0 (334.5–471.5) 248.8 (205.9–291.7)* 248.4 (210.2–286.7)*
Respiratory rate (brpm) 113.0 (49.5–176.5) 96.0 (0–197.7) 64.5 (49.8–79.2) 58.3 (44.7–72.0)
10 Heart rate (bpm) 393.2 (294.9–491.6)** 369.1 (336.8–455.5) 229.7 (166.0–293.4)* 241.8 (215.4–268.3)*
Respiratory rate (brpm) 91.3 (47.6–135.1) 95.2 (50.7–139.8) 71.7 (40.2–103.3) 72.3 (48.4–96.3)
15 Heart rate (bpm) 304.0 (225.1–382.8) 294.8 (124.3–465.3) 253.5 (231.7–275.3) 244.4 (221.6–267.2)
Respiratory rate (brpm) – 67.0 (0–321.1) 61.5 (52.4–70.6) 53.0 (29.8–76.2)
20 Heart rate (bpm) 300.5 (0–1272.5) 261.3 (198.2–324.5) 274.4 (220.9–273.9) 229.4 (207.3–251.5)
Respiratory rate (brpm) – 83.3 (–17.9–184.6) 70.7 (52.5–88.8) 55.7 (26.4–85.1)
25 Heart rate (bpm) – 295.7 (161.6–429.8) 230.0 (208.9–251.1)* 218.9 (194.4–243.3)*
Respiratory rate (brpm) – – 54.7 (39.8–69.6) 60.0 (17.5–102.4)
30 Heart rate (bpm) – 325.7 (278.9–372.6) 224.7 (199.7–249.7)* 204.9 (165.3–244.4)*
Respiratory rate (brpm) – 95.0 (36.5–153.5) 68.6 (23.4–113.8) 63.2 (41.3–85.2)
35 Heart rate (bpm) – 285.7 (93.2–478.3) 182.0 (86.1–277.9) 217.0 (198.8–235.2)
Respiratory rate (brpm) – 127.3 (105.9–148.7) 66.7 (40.3–93.0) 69.0 (37.1–100.8)
40 Heart rate (bpm) – 334.5 (137.6–531.4) 213.8 (185.6–242.0) 214.7 (193.5–235.9)
Respiratory rate (brpm) – – 64.0 (39.2–88.8) 67.7 (41.4–94.1)
45 Heart rate (bpm) – 348.0 (–325.4–1021.4) 171.9 (98.5–245.2)* 218.5 (199.1–237.9)*
– – 70.0 (57.1–82.9) 78.4 (39.5–117.3)
50 Heart rate (bpm) – 402.0 (58.9–745.1) 188.0 (142.2–233.8) 208.0 (177.6–238.4)
Respiratory rate (brpm) – – 60.4 (46.3–74.5) 59.0 (10.1–107.9)
55 Heart rate (bpm) – 334.5 (74.0–594.9) 200.3 (176.5–224.0) 213.4 (191.9–234.9)
Respiratory rate (brpm) – – 60.0 (53.7–66.3) 79.0 (31.0–127.0)
60 Heart rate (bpm) – – 201.1 (175.6–226.7) 205.8 (177.5–234.1)
Respiratory rate (brpm) – – 73.5 (59.7–87.3) 69.0 (0–323.1)
KET: 100 mg/kg of ketamine; KET/MID: 100 mg/kg of ketamine and 5 mg/kg of midazolam in a single injection; KET/DEX: 100 mg/kg of
ketamine and 0.25 mg/kg of dexmedetomidine in a single injection; KET/DEXþA: 100 mg/kg of ketamine and 0.25 mg/kg of dexmedeto-
midine in a single injection, and 5 mg/kg of atipamezole one hour post-anaesthesia; bpm: beats per minute; brpm: breaths per minute.
Data are shown as median (95% confidence interval). *P 0.043 for comparison with KET/MID; **P¼ 0.039 for comparison with KET/
DEXþA. When no value is exhibited this implies that the animals were too superficial, and the equipment could not measure the variable.
Figure 1. Reference (a) and working (b) memory errors tested in radial maze in rats exposed to ketamine alone, or
combined with midazolam or dexmedetomidine. Results are presented as meansþSEM (n¼ 6) for groups: saline solution
(CONTROL); 100 mg/kg ketamine (KET); 100 mg/kg ketamine and 5 mg/kg midazolam (KET/MID); and 100 mg/kg ketamine
and 0.25 mg kg dexmedetomidine (KET/DEX); block session was calculated as average measured on five trials. No dif-
ferences between groups were observed.
(57.2 [13.9–128.2] s) (U¼ 5.000, Z¼2.802,
P< 0.05). There were no significant differences between
groups in the other studied parameters (Table 2).
In the EPM task there were no significant differences
between groups (Table 3).
Discussion
This study shows that ketamine alone or in combin-
ation with midazolam or dexmedetomidine does not
affect spatial and recognition memory or emotional
reactivity in rats. We chose to perform the tests 48 h
after anaesthesia, since we intended to study not the
direct effect of the substances, but the possible long-
term and side-effects when the anaesthetics were no
longer in the animals. This time frame was chosen
since the half-life of ketamine administered intramus-
cularly is 33min,25 and the half-life of midazolam
administered intravenously is 29.4min26 in rats.
Dexmedetomidine has been described with a half-life
of approximately 2 h.27
Results from anaesthesia variables revealed that ani-
mals anaesthetized with ketamine / dexmedetomidine
had a lower heart rate and a greater depth of
Figure 2. Object recognition (OR) and object location (OL) memory tests in rats exposed to ketamine alone, or combined
with midazolam or dexmedetomidine. Schematic representation of the experimental design: 2A: habituation (5 days); 2B:
OR1 – sample phase of OR; OR2 – choice phase, delay 15 min, graphs represent duration of object exploration and
discrimination index for object exploration in OR2; 2C: OR3 – choice phase, delay 24 h, graphs represent duration of object
exploration and discrimination index for object exploration in OR3; 2D: OL1 – sample phase of OL; OL2 – choice phase,
delay 15 min, graphs represent duration of object exploration and discrimination index for object exploration in OL2.
Individual values are shown for each experimental group, n¼ 6. The large horizontal bars represent mean values for each
group, and the vertical bars represent the SEM. Groups: saline solution (CONTROL); 100 mg/kg ketamine (KET); 100 mg/kg
ketamine and 5mg/kg midazolam (KET/MID); and 100 mg/kg ketamine and 0.25mg/kg dexmedetomidine (KET/DEX). No
differences between groups were observed. *P< 0.05, **P< 0.01 and ***P< 0.001 indicate significant differences within
groups.
anaesthesia when compared with ketamine / midazolam
treated rats.28 Indeed, the pedal withdrawal reflex was
only lost in rats from the KET/DEX and KET/
DEXþA groups, implying that surgical anaesthesia
was only achieved with these combinations.
Nevertheless, the other protocols have been proven to
be useful in other situations. For example, ketamine
alone causes a loss of righting reflex and induces a shal-
low plane of anaesthesia for 30min, which is suitable
for imaging procedures when only immobility is
required. In addition to imaging, ketamine/midazolam
anaesthesia may also be adequate for minor procedures
such as blood collection, venepuncture/catheter place-
ment, and subcutaneous implantation of devices.
The heart rate of animals treated with KET was
higher than that of the KET/DEX and KET/DEXþA
rats. In general, these results are in agreement with
those found in the literature. Ketamine is expected to
Table 2. Descriptive analysis, median, confidence interval (CI) and P value for the parameters evaluated in the new object
exploration (NOE) test.
Parameters measured CONTROL KET KET/MID KET/DEX P value
Arena exploration (s) 278.5 (244.1–312.9) 314.8 (272.1–357.6) 278.2 (154.4–401.9) 233.8 (158.0–309.6) 0.107
Centre exploration (s) 67.2 (44.6–89.7) 89.7 (64.2–115.2) 67.5 (33.8–101.2) 60.0 (9.0–111.0) 0.264
Periphery exploration (s) 211.3 (192.8–229.8) 255.2 (168.7–281.7) 210.7 (118.3–303.1) 173.2 (142.1–204.3) 0.264
Time in the centre (%) 22.7 (15.2–30.1) 29.7 (19.1–40.3) 21.2 (9.9–32.5) 16.7 (5.0–28.3) 0.183
Number visits centre 67.2 (48.2–86.1) 93.5 (57.2–129.7) 71.2 (36.1–106.3) 47.3 (13.5–81.2) 0.153
Corner behaviour (s) *57.2 (0–128.2) #33.7 (9.0–58.4) 138.7 (–41.3–318.5) *#173.0(49.7–297.3) *0.037
#0.010
Latency to explore object (s) 14.8 (–3.1–32.8) 19.8 (4.2–35.5) 30.0(4.73–55.3) 39.7(33.7–45.6) 0.103
Object exploration (s) 45.3 (24.1–66.6) 55.8 (25.4–86.2) 43.8 (7.5–26.5) 30.5 (3.48–15.2) 0.551
Object approach (f) 16.3 (11.5–21.2) 20.3 (11.4–29.3) 17.0 (7.5–26.5) 9.3 (3.5–15.2) 0.091
Risk assessment posture (f) 0.7 (–0.2–1.5) 2.2 (–0.4–4.8) 2.3 (–1.7–6.4) 0.5 (–0.07–1.07) 0.293
Rearing (f) 65.5 (53.5–77.5) 89.0 (38.9–99.1) 44.0 (24.9–63.1) 47.5(–33.4–61.6) 0.072
Grooming (s) 26.8 (15.7–38.0) 23.0 (10.7–35.3) 22.8 (0.2–45.4) 41.2 (11.0–71.4) 0.346
Grooming (f) 6.2 (4.8–7.6) 5.2 (3.2–7.1) 4.2 (0.5–7.8) 7.7 (2.3–13.1) 0.329
KET: 100 mg/kg of ketamine; KET/MID: 100 mg/kg of ketamine and 5 mg/kg of midazolam; KET/DEX: 100 mg/kg of ketamine and 0.25 mg/
kg of dexmedetomidine; CONTROL: saline injection; n¼ 6; s: duration of the behaviour; f: frequency of the behaviour. Data were analysed
with Kruskal–Wallis test followed by the Mann–Whitney U-test and expressed by median and 95% CI. *P< 0.05 indicates significant
differences between control and KET/DEX; #p< 0.05 indicates significant difference between KET and KET/DEX.
Table 3. Parameters measured in the elevated plus maze test.
Parameters measured CONTROL KET KET/MID KET/DEX KET/DEXþA P value
Time in open arm (%) 2 (3–37) 17 (3–37) 7 (2–11) 6 (2–9) 18 (5–31) 0.267
Time in close arm (%) 63 (47–79) 68 (42–93) 76 (62–91) 82 (77–88) 67 (50–83) 0.357
Time in centre (%) 17 (11–23) 15 (7–23) 16 (4–30) 12 (7–17) 15 (8–22) 0.935
Open arm entries (f) 3.5 (1.9–5.1) 2.7 (0.1–5.3) 2.0 (0.6–3.4) 2.0 (1.2–2.8) 3.4 (0.8–6.1) 0.520
Close arm entries (f) 5.8 (4.2–7.5) 4.0 (3.2–4.6) 5.0 (2.3–7.7) 3.1 (2.0–4.3) 2.1 (2.1–6.5) 0.520
Total arm entries (f) 9.3 (7.3–11.4) 6.7 (3.6–9.8) 7.0 (3.6–10.4) 5.1 (4.2–6.1) 7.7 (3.3–12.2) 0.261
Locomotion (s) 21.2 (3.8–38.5) 9.1 (4.6–13.7) 10.9 (5,6–16.3) 6.8 (2.2–11.4) 10.3 (3.1–17.5) 0.524
Head dipping (f) 11.7 (3.1–20.3) 10.7 (3.0–18.4) 8.0 (2.7–13.3) 5.4 (3.1–7.8) 9.6 (4.1–15.0) 0.432
Rearing (s) 37.9 (–16.6–59.1) 38.1 (14.6–61.6) 28.8 (16.9–40.7) 23.7 (13.8–67.1) 40.5 (17.4–30.2) 0.508
Immobility (s) 21.7 (–10.3–53.8) 53.2 (–7.0–77.5) 50.9 (–15.2 117) 74.3 (37.2–111) 43.7 (–9.6–97.0) 0.294
SAP (f) 8 (2.9–13.1) 5.3 (0.6–9.9) 5.4 (–0.2–11.1) 4.9 (0.8–8.8) 4.3 (1.5–7.1) 0.694
Latency (s) 63.5 (13.2–113.8) 128.3 (2.1–254.5) 123 (5.9–251.9) 75.1 (–7.1–157.4) 64.9 (–33.2–162.9) 0.948
Grooming (s) 2.9 (–4.5–10.2) 4.7 (–2.7–12.2) 4.4 (–2.9–11.8) 8.5 (–2.4–19.4) 7.2 (–4.9–19.3) 0.592
No. feacal boli (f) 2.7 (0.9–4.4) 3.3 (0.6–5.9) 3.1 (0.9–5.4) 2.1 (0.3–3.8) 3.1 (0.6–5.7) 0.875
KET: 100 mg/kg of ketamine; KET/MID: 100 mg/kg of ketamine and 5 mg/kg of midazolam; KET/DEX: 100 mg/kg of ketamine and 0.25 mg/
kg of dexmedetomidine; KET/DEXþA: 100 mg/kg of ketamine and 0.25 mg/kg of dexmedetomidine reverted with 5mg/kg of atipamezole
one hour post-anaesthesia; CONTROL: saline injection; SAP: Stretched Attend Posture; n¼ 7, except for control with 6; f: frequency of the
behaviour. Data are reported as median and 95% confidence interval.
oppose the depressant actions of a2-agonists and
benzodiazepines on the circulatory system.16,29,30 In
humans, the combination of ketamine with dexmedeto-
midine provides a stable anaesthesia, with a reduction
of adverse effects caused by ketamine, such as post-
anaesthetic delirium.16 Furthermore, the use of a2-
agonists reduces anaesthetic requirements and
improves perioperative haemodynamic stability.31,32
In addition, ketamine/dexmedetomidine anaesthesia
has the advantage of allowing rapid recovery with the
administration of atipamezole, a specific a2-antagonist
available for animal use, which immediately reverses
dexmedetomidine effects.33 Both animal and human
studies have shown that ketamine combined with mid-
azolam and diazepam results in fewer side-effects and
better recovery than the use of ketamine alone.34,35
However, there is still a lack of information about
potential secondary effects on cognitive functions of
these combined drugs.
Although the scope of this study was to evaluate the
effects of ketamine combinations, the use of 100mg/kg
of ketamine alone was important as a control dose for
the anaesthetic combinations used. As has already been
mentioned, several studies have reported ketamine-
induced neurotoxicity and psychotic symptoms.
Therefore, if anaesthetic combinations result in
memory impairment or changes in anxiety levels, it is
imperative to rule out the possibility of a direct influ-
ence of ketamine alone. In this sense, the results of
animals treated with ketamine alone may provide
insight for other researchers.
The behavioural analysis performed in this study
demonstrated that spatial and recognition memory
were unimpaired in adult rats 48 h post-anaesthesia
with ketamine alone or in combination with midazolam
or dexmedetomidine. All groups learned the radial
maze task, as shown by the decreasing number of work-
ing and reference memory errors over time.
Furthermore, all animals showed a decrease in response
latency, a measure that seems to reflect appetitive
motivational demands.36 Thus, it is suggested that the
anaesthetic protocols used did not induce alterations in
the motivation to locate the rewards, which is essential
for a proper performance of the complex learning tasks
used in neuroscience research.
Data concerning the effects of the combined adminis-
tration of ketamine with midazolam or dexmedetomidine
on spatial memory in rodents are scarce. Nevertheless,
a previous study using the T-maze test showed that keta-
mine alone or in combination with medetomidine had no
effects on spatial learning in mice,20 and also that keta-
mine alone did not interfere with radial maze learning.24
Similar results were obtained in mice treated with keta-
mine/midazolam when tested in the radial maze.18
Nevertheless, sub-anaesthetic37 and anaesthetic38
doses of ketamine, administered minutes before the
spatial tasks caused impairment in the acquisition
of the referred tasks. With the same anaesthetic dose
(100mg/kg), our results shows that ketamine alone
has no effect on spatial memory, suggesting that
an increased time period between administration
and training could be enough to avoid these
ketamine-induced effects on memory acquisition.
In the present study, animals from the different
experimental groups exhibited a robust recognition
memory, as defined by the preferential exploration of
the novel object/location over the familiar object/loca-
tion, and a similar discrimination index. In the test
phase of the OR trial, animals have to detect and to
encode a novel object, while making the update and
reconsolidation of the familiar object.39 Even in the
more demanding trials, with a long delay (24 h) between
the sample and the choice phase, this cognitive process
was not impaired using our anaesthesia protocols.
Corroborating our results, Pitsikas and colleagues40
have reported that acute administration of ketamine
(100mg/kg) did not induce impairments in recognition
memory, 48 h or 72 h after treatment and with a 24 h
delay for object recognition or object location, respect-
ively. Hou et al.41 have also reported that the same
ketamine dose did not interfere with the retention of
the novel object recognition memory in mice.
Furthermore, this anaesthetic procedure had no effect,
up to seven days post-treatment,41 on neurons of the
prefrontal cortex and hippocampus, which are the
brain regions responsible for recognition, spatial
memory,42 and working memory.43 It has been previ-
ously demonstrated by our group that chronic lower
doses of ketamine (5mg/kg) impaired performance in
the OR/L test.13 To our knowledge, the present work is
the first study to assess how a single dose of both com-
binations of ketamine/midazolam and ketamine/dex-
medetomidine affects object recognition memory.
In the NOE test, animal responses may reflect anx-
iety and/or fear, which is reflected in the avoidance
activity or exploring the new object.44 Here, all
groups exhibited a similar response to the new object;
in general, all treatment groups had emotional reactiv-
ity similar to control levels 48 h post-anaesthesia.
However, rats in the KET/DEX group spent signifi-
cantly more time in corner behaviour than the
CONTROL and KET groups. This behaviour repre-
sents a thigmotactic response, a natural defensive
response in which rats remain close to vertical surfaces.
Therefore, this result suggests that ketamine/dexmede-
tomidine treated animals show an increased anxiety and/
or fear-like behaviour.
In order to corroborate the NOE results, a more
robust and classical test for anxiety, EPM, was per-
formed. The space occupation in this task reflects a
conflict between the rodent’s preference for protected
areas (e.g. closed arms) and their innate motivation to
explore novel environments, such as the open arms.45
An increased time spent and a higher number of entries
in the open arms are generally interpreted as a decrease
in anxiety-like behaviour.46 Since the differences
detected in the NOE test involved the group (KET/
DEX) that had anaesthesia duration more than three
times longer than the other groups, we also tested the
KET/DEXþA group. These animals were treated with
ketamine/dexmedetomidine and, after one hour, anaes-
thesia was reverted with atipamezole (an a2-adrenergic
antagonist). This procedure was included in order to
control anaesthesia duration, which could be a variable
inducing the results previously referred to. Our data
showed that the different anaesthetic protocols used
did not affect space occupation in the EPM apparatus.
Other ethological measures registered, such as the
number of rears, head dips, faecal boli, freezing or
stretched-attend postures, were also not affected by
the anaesthetic protocols.
Overall, our results clarified the NOE test outcomes,
supporting the absence of effects of the anaesthetic
protocols used on emotional behaviour. Low ketamine
doses, such as 20mg/kg, may be anxiogenic,47 while
doses which are higher, but lower than our dose,
result in anxiolytic-related behaviour.48 Nevertheless,
these results were obtained when ketamine was admin-
istered a few minutes to 2 h before the EPM test. In
humans, studies of anxiety induced by ketamine are
few; and in these studies ketamine does not seem to
interfere with anxiety issues, even three days after
administration.49 These studies are in agreement and
support, to some extent, our data obtained 48 h post-
anaesthesia. Concerning ketamine combinations, little
is known about their effects on anxiety, except that
dexmedetomidine and midazolam are considered to
be anxiolytics.16,30 In humans, both drugs may be
given to ketamine-anaesthetized patients in order to
induce sedation and anxiolysis; however, these effects
are not usually evaluated in the long term, such as after
discharge from the post-anaesthesia care unit.16
Therefore, besides the described ketamine side-
effects,6 it is important to highlight the absence of keta-
mine memory impairment and alterations on emotional
reactivity in our results. These outcomes contradict sev-
eral reports in rodents which can be explained by meth-
odological differences such as different dose effects
(sub-anaesthetic versus anaesthestic doses37), age
(young and elderly may be more susceptible to anaes-
thetic toxicity50,51), frequency of administration (acute
versus chronic13), time between anaesthesia and behav-
ioural evaluation,38 study of different memory pro-
cesses,52 and temperature.40 In accordance, human
studies have consistently reported that acute ketamine
administration induces short-term psychotic events and
transient memory impairment without causing seque-
lae.53 With these reports, the variables inherent in clin-
ical settings, painful and stressful procedures, and the
large diversity of individuals must all be taken into con-
sideration. The use of animal models enables us to
overcome these limitations by using a controlled envir-
onment, and no surgery or other invasive procedures in
order to study the sole effects of anaesthetics.
As previously stated, the potential effects of anaesthe-
sia in neurobehavioural experiments depend on several
factors; thus, there is not simply one appropriate time
interval from anaesthesia to behavioural assessments to
avoid anaesthesia-related effects. Nevertheless, neurobe-
havioural experiments may be conducted without
expecting long-term anaesthesia effects 48 h after a
single injection of 100mg/kg ketamine and its combin-
ations (midazolam, medetomidine, dexmedetomi-
dine).18,19,20,24 Other anaesthetic protocols may be
used for this purpose, such as high concentrations of
isoflurane,54,55 sevoflurane and desflurane.56 However,
injectable anaesthesia has the advantage of not requiring
any special equipment as volatile anaesthesia does. In
addition, injectable anaesthetics are needed to promote
balanced anaesthesia. Other anaesthetic protocols such
as propofol/medetomidine/fentanyl,57,58 and ketamine
combined with other benzodiazepines (diazepam) and
a-2 agonists (xylazine) are suitable for use in laboratory
rodents;59 however, further studies are needed regarding
their effects at the neurobehavioural level.
In summary, our results show that despite the uncon-
sciousness time varying across the anaesthetic protocols
used (ketamine alone, or in combination with midazo-
lam or dexmedetomidine), spatial, recognition memory
and anxiety-like behaviours are not affected in adult
rats. These results indicate that, in adult rats, the
tested anaesthetic combinations and doses do not
induce long-term effects regarding memory. Although
midazolam and dexmedetomidine are considered to
have anxiolytic properties, our results show that after
48 h, these drugs do not affect emotional behaviour.
Thus, our results suggest that these combinations are
useful for rat anaesthesia and/or sedation procedures
in clinical and neurobehavioural research without com-
promising the quality of the outcomes. Therefore, the
use of anaesthesia in laboratory rodents, namely these
protocols, should always be considered in order to refine
procedures and decrease rodent pain and distress.
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